Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1996 Aug;40(8):1889–1892. doi: 10.1128/aac.40.8.1889

Efficacy of clarithromycin treatment of acute otitis media caused by infection with penicillin-susceptible, -intermediate, and -resistant Streptococcus pneumoniae in the chinchilla.

C M Alper 1, W J Doyle 1, J T Seroky 1, C D Bluestone 1
PMCID: PMC163435  PMID: 8843299

Abstract

Because of the increasing frequencies of recovery of penicillin-resistant Streptococcus pneumoniae from the middle ears of children with acute otitis media, non-beta-lactam antibiotics are being explored as treatment alternatives to amoxicillin. In this study, the efficacy of a 10-day course of clarithromycin was evaluated with chinchillas. After the pharmacokinetic profiles for clarithromycin were established, 180 animals were assigned to one of three susceptibility groups (n = 60/group; penicillin-susceptible, -intermediate, and -resistant S. pneumoniae), and the right middle ear was infected with the appropriate strain of S. pneumoniae. Equal numbers of animals in each group were treated orally beginning on day 2 with a 10-day course of clarithromycin (15 mg/kg of body weight; given twice a day) or amoxicillin as a control (20 mg/kg twice a day). On days 4, 9, and 13, otomicroscopy and tympanometry were performed, and on day 13, the middle ears were cultured for bacteria. The results showed 100% eradication of the challenge organism in both treatment groups for the susceptible strains of S. pneumoniae. Cultures were negative in 87 and 74% (P > 0.05) of the animals challenged with the intermediate resistant strains and in 100 and 56% (P < 0.05) of the animals challenged with the resistant strains and treated with clarithromycin and amoxicillin, respectively. There were no differences between treatments in the diagnosis of effusion for any group. These results support the use of the chinchilla to evaluate drug efficacy in the treatment of acute otitis media and show clarithromycin to be effective in sterilizing the middle ears of animals challenged with penicillin-susceptible, -intermediate, and -resistant strains of S. pneumoniae.

Full Text

The Full Text of this article is available as a PDF (186.7 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aspin M. M., Hoberman A., McCarty J., McLinn S. E., Aronoff S., Lang D. J., Arrieta A. Comparative study of the safety and efficacy of clarithromycin and amoxicillin-clavulanate in the treatment of acute otitis media in children. J Pediatr. 1994 Jul;125(1):136–141. doi: 10.1016/s0022-3476(94)70140-7. [DOI] [PubMed] [Google Scholar]
  2. Barry B., Muffat-Joly M., Gehanno P., Pocidalo J. J. Effect of increased dosages of amoxicillin in treatment of experimental middle ear otitis due to penicillin-resistant Streptococcus pneumoniae. Antimicrob Agents Chemother. 1993 Aug;37(8):1599–1603. doi: 10.1128/aac.37.8.1599. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bluestone C. D., Stephenson J. S., Martin L. M. Ten-year review of otitis media pathogens. Pediatr Infect Dis J. 1992 Aug;11(8 Suppl):S7–11. doi: 10.1097/00006454-199208001-00002. [DOI] [PubMed] [Google Scholar]
  4. Chan K. H., Swarts J. D., Doyle W. J., Tanpowpong K., Kardatzke D. R. Efficacy of a new macrolide (azithromycin). For acute otitis media in the chinchilla model. Arch Otolaryngol Head Neck Surg. 1988 Nov;114(11):1266–1269. doi: 10.1001/archotol.1988.01860230060024. [DOI] [PubMed] [Google Scholar]
  5. Chesney P. J. The escalating problem of antimicrobial resistance in Streptococcus pneumoniae. Am J Dis Child. 1992 Aug;146(8):912–916. doi: 10.1001/archpedi.1992.02160200034022. [DOI] [PubMed] [Google Scholar]
  6. Diven W. F., Evans R. W., Alper C., Burckart G. J., Jaffe R., Doyle W. J. Treatment of experimental acute otitis media with ibuprofen and ampicillin. Int J Pediatr Otorhinolaryngol. 1995 Oct;33(2):127–139. doi: 10.1016/0165-5876(95)01196-i. [DOI] [PubMed] [Google Scholar]
  7. Faden H., Bernstein J., Brodsky L., Stanievich J., Ogra P. L. Effect of prior antibiotic treatment on middle ear disease in children. Ann Otol Rhinol Laryngol. 1992 Jan;101(1):87–91. doi: 10.1177/000348949210100119. [DOI] [PubMed] [Google Scholar]
  8. Fernandes P. B., Ramer N., Rode R. A., Freiberg L. Bioassay for A-56268 (TE-031) and identification of its major metabolite, 14-hydroxy-6-O-methyl erythromycin. Eur J Clin Microbiol Infect Dis. 1988 Feb;7(1):73–76. doi: 10.1007/BF01962181. [DOI] [PubMed] [Google Scholar]
  9. Fraschini F., Scaglione F., Pintucci G., Maccarinelli G., Dugnani S., Demartini G. The diffusion of clarithromycin and roxithromycin into nasal mucosa, tonsil and lung in humans. J Antimicrob Chemother. 1991 Feb;27 (Suppl A):61–65. doi: 10.1093/jac/27.suppl_a.61. [DOI] [PubMed] [Google Scholar]
  10. Friedland I. R., McCracken G. H., Jr Management of infections caused by antibiotic-resistant Streptococcus pneumoniae. N Engl J Med. 1994 Aug 11;331(6):377–382. doi: 10.1056/NEJM199408113310607. [DOI] [PubMed] [Google Scholar]
  11. Guenzi E., Gasc A. M., Sicard M. A., Hakenbeck R. A two-component signal-transducing system is involved in competence and penicillin susceptibility in laboratory mutants of Streptococcus pneumoniae. Mol Microbiol. 1994 May;12(3):505–515. doi: 10.1111/j.1365-2958.1994.tb01038.x. [DOI] [PubMed] [Google Scholar]
  12. Hardy D. J., Guay D. R., Jones R. N. Clarithromycin, a unique macrolide. A pharmacokinetic, microbiological, and clinical overview. Diagn Microbiol Infect Dis. 1992 Jan;15(1):39–53. doi: 10.1016/0732-8893(92)90055-x. [DOI] [PubMed] [Google Scholar]
  13. Hotaling A. J., Doyle W. J., Cantekin E. I. Efficacy of a new cephalosporin for acute otitis media. Arch Otolaryngol Head Neck Surg. 1987 Apr;113(4):370–373. doi: 10.1001/archotol.1987.01860040032011. [DOI] [PubMed] [Google Scholar]
  14. Marchant C. D., Carlin S. A., Johnson C. E., Shurin P. A. Measuring the comparative efficacy of antibacterial agents for acute otitis media: the "Pollyanna phenomenon". J Pediatr. 1992 Jan;120(1):72–77. doi: 10.1016/s0022-3476(05)80601-8. [DOI] [PubMed] [Google Scholar]
  15. Mason E. O., Jr, Kaplan S. L., Lamberth L. B., Tillman J. Increased rate of isolation of penicillin-resistant Streptococcus pneumoniae in a children's hospital and in vitro susceptibilities to antibiotics of potential therapeutic use. Antimicrob Agents Chemother. 1992 Aug;36(8):1703–1707. doi: 10.1128/aac.36.8.1703. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. McCracken G. H., Jr Selection of antimicrobial agents for treatment of acute otitis media with effusion. Pediatr Infect Dis J. 1987 Oct;6(10):985–988. doi: 10.1097/00006454-198710000-00039. [DOI] [PubMed] [Google Scholar]
  17. Rosenfeld R. M., Doyle W. J., Swarts J. D., Seroky J., Greene I. Efficacy of ceftibuten for acute otitis media caused by Hemophilus influenzae: an animal study. Ann Otol Rhinol Laryngol. 1993 Mar;102(3 Pt 1):222–226. doi: 10.1177/000348949310200310. [DOI] [PubMed] [Google Scholar]
  18. Rosenfeld R. M., Vertrees J. E., Carr J., Cipolle R. J., Uden D. L., Giebink G. S., Canafax D. M. Clinical efficacy of antimicrobial drugs for acute otitis media: metaanalysis of 5400 children from thirty-three randomized trials. J Pediatr. 1994 Mar;124(3):355–367. doi: 10.1016/s0022-3476(94)70356-6. [DOI] [PubMed] [Google Scholar]
  19. Spika J. S., Facklam R. R., Plikaytis B. D., Oxtoby M. J. Antimicrobial resistance of Streptococcus pneumoniae in the United States, 1979-1987. The Pneumococcal Surveillance Working Group. J Infect Dis. 1991 Jun;163(6):1273–1278. doi: 10.1093/infdis/163.6.1273. [DOI] [PubMed] [Google Scholar]
  20. Zenni M. K., Cheatham S. H., Thompson J. M., Reed G. W., Batson A. B., Palmer P. S., Holland K. L., Edwards K. M. Streptococcus pneumoniae colonization in the young child: association with otitis media and resistance to penicillin. J Pediatr. 1995 Oct;127(4):533–537. doi: 10.1016/s0022-3476(95)70108-7. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES